Cargando…
Impact of a Shortage of First-Line Antituberculosis Medication on Tuberculosis Control — United States, 2012–2013
Autores principales: | Warkentin, Jon, Flood, Jennifer, True, Lisa, Kanouse, Jennifer, Shah, Neha, Mase, Sundari R., Cronin, Ann, Chorba, Terence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
U.S. Centers for Disease Control
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604936/ https://www.ncbi.nlm.nih.gov/pubmed/23698604 |
Ejemplares similares
-
Interruptions in Supplies of Second-Line Antituberculosis Drugs — United States, 2005–2012
por: Seaworth, Barbara J., et al.
Publicado: (2013) -
National Shortage of Purified-Protein Derivative Tuberculin Products
por: Jereb, John, et al.
Publicado: (2013) -
Cost Resulting from Anti-Tuberculosis Drug Shortages in the United States: A Hypothetical Cohort Study
por: Scott, James C., et al.
Publicado: (2015) -
Correction: Cost Resulting from Anti-Tuberculosis Drug Shortages in the United States: A Hypothetical Cohort Study
por: Scott, James C., et al.
Publicado: (2015) -
Extent and Effects of Recurrent Shortages of Purified-Protein Derivative Tuberculin Skin Test Antigen Solutions — United States, 2013
por: Turner, Rebekah E., et al.
Publicado: (2013)